131 related articles for article (PubMed ID: 24796502)
1. A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth.
Alves ID; Carré M; Montero MP; Castano S; Lecomte S; Marquant R; Lecorché P; Burlina F; Schatz C; Sagan S; Chassaing G; Braguer D; Lavielle S
Biochim Biophys Acta; 2014 Aug; 1838(8):2087-98. PubMed ID: 24796502
[TBL] [Abstract][Full Text] [Related]
2. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.
Arouri A; Dathe M; Blume A
Biophys Chem; 2013; 180-181():10-21. PubMed ID: 23792704
[TBL] [Abstract][Full Text] [Related]
3. Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution.
Alves ID; Goasdoué N; Correia I; Aubry S; Galanth C; Sagan S; Lavielle S; Chassaing G
Biochim Biophys Acta; 2008; 1780(7-8):948-59. PubMed ID: 18498774
[TBL] [Abstract][Full Text] [Related]
4. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy.
Jung HK; Kim S; Park RW; Park JY; Kim IS; Lee B
J Control Release; 2016 Aug; 235():259-267. PubMed ID: 27282414
[TBL] [Abstract][Full Text] [Related]
5. Potential-dependent membrane permeabilization and mitochondrial aggregation caused by anticancer polyarginine-KLA peptides.
Lemeshko VV
Arch Biochem Biophys; 2010 Jan; 493(2):213-20. PubMed ID: 19900399
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria-disrupting peptides.
Yang H; Liu S; Cai H; Wan L; Li S; Li Y; Cheng J; Lu X
J Biol Chem; 2010 Aug; 285(33):25666-76. PubMed ID: 20484051
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis.
Orzáez M; Mondragón L; Marzo I; Sanclimens G; Messeguer A; Pérez-Payá E; Vicent MJ
Peptides; 2007 May; 28(5):958-68. PubMed ID: 17408805
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity.
Hao W; Hu C; Huang Y; Chen Y
PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065
[TBL] [Abstract][Full Text] [Related]
9. Vesicles mimicking normal and cancer cell membranes exhibit differential responses to the cell-penetrating peptide Pep-1.
Almarwani B; Phambu EN; Alexander C; Nguyen HAT; Phambu N; Sunda-Meya A
Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1394-1402. PubMed ID: 29621495
[TBL] [Abstract][Full Text] [Related]
10. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
11. iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice.
Qifan W; Fen N; Ying X; Xinwei F; Jun D; Ge Z
Tumour Biol; 2016 Aug; 37(8):10643-52. PubMed ID: 26867766
[TBL] [Abstract][Full Text] [Related]
12. Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
Huang Y; Li X; Sha H; Zhang L; Bian X; Han X; Liu B
Oncol Rep; 2017 Apr; 37(4):2063-2070. PubMed ID: 28260064
[TBL] [Abstract][Full Text] [Related]
13. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12.
Sun W; Li L; Li LJ; Yang QQ; Zhang ZR; Huang Y
Acta Pharmacol Sin; 2017 Jun; 38(6):806-822. PubMed ID: 28065935
[TBL] [Abstract][Full Text] [Related]
14. Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry.
Joanne P; Galanth C; Goasdoué N; Nicolas P; Sagan S; Lavielle S; Chassaing G; El Amri C; Alves ID
Biochim Biophys Acta; 2009 Sep; 1788(9):1772-81. PubMed ID: 19427300
[TBL] [Abstract][Full Text] [Related]
15. An in-tether chiral center modulates the proapoptotic activity of the KLA peptide.
Li J; Hu K; Chen H; Wu Y; Chen L; Yin F; Tian Y; Li Z
Chem Commun (Camb); 2017 Sep; 53(75):10452-10455. PubMed ID: 28884757
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities.
Hyun S; Lee S; Kim S; Jang S; Yu J; Lee Y
Biomacromolecules; 2014 Oct; 15(10):3746-52. PubMed ID: 25188534
[TBL] [Abstract][Full Text] [Related]
17. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.
Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH
J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326
[TBL] [Abstract][Full Text] [Related]
18. The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells.
Jobin ML; Bonnafous P; Temsamani H; Dole F; Grélard A; Dufourc EJ; Alves ID
Biochim Biophys Acta; 2013 Jun; 1828(6):1457-70. PubMed ID: 23462641
[TBL] [Abstract][Full Text] [Related]
19. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity.
Law B; Quinti L; Choi Y; Weissleder R; Tung CH
Mol Cancer Ther; 2006 Aug; 5(8):1944-9. PubMed ID: 16928814
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Peptide K
Enoki TA; Moreira-Silva I; Lorenzon EN; Cilli EM; Perez KR; Riske KA; Lamy MT
Langmuir; 2018 Feb; 34(5):2014-2025. PubMed ID: 29284086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
